July 9, 2019 / 11:19 PM / 3 months ago

Appeals court mulls reviving Merck's $2.54 billion patent win against Gilead

A federal appeals court on Tuesday was considering whether to reinstate a $2.54 billion jury verdict Merck & Co Inc won against Gilead Sciences Inc in a dispute over hepatitis C treatments — the largest ever in a patent infringement case.

A three-judge panel of the U.S. Court of Appeals for the Federal Circuit heard oral arguments in Merck’s appeal of a judge’s post-trial decision invalidating the patent at issue in the case.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2XB324C

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below